ResearcherBC Cancer AgencyActive in the last 2 years
Paul C. McDonald
Matched on ORCID iD 0000-0002-7238-2912; OpenAlex author ID A5008627536, A5109645110. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper
Papers 3
- Pancreatic cancer tumor organoids exhibit subtype-specific differences in metabolic profiles. Co-author DOI 10.1186/s40170-024-00357-z↗
- Overcoming Adaptive Resistance to KRAS and MEK Inhibitors by Co-targeting mTORC1/2 Complexes in Pancreatic Cancer. First author DOI 10.1016/j.xcrm.2020.100131↗
- Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia. Co-author DOI 10.1053/j.gastro.2019.05.004↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- David F. Schaeffer · 3 shared papers, 2019–2024 · strength 0.36
- Paper Pancreatic cancer tumor organoids exhibit subtype-specific differences in metabolic profiles. DOI 10.1186/s40170-024-00357-z↗
- Paper Overcoming Adaptive Resistance to KRAS and MEK Inhibitors by Co-targeting mTORC1/2 Complexes in Pancreatic Cancer. DOI 10.1016/j.xcrm.2020.100131↗
- Paper Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response t… DOI 10.1053/j.gastro.2019.05.004↗
- Daniel John Renouf · 3 shared papers, 2019–2024 · strength 0.36
- Paper Pancreatic cancer tumor organoids exhibit subtype-specific differences in metabolic profiles. DOI 10.1186/s40170-024-00357-z↗
- Paper Overcoming Adaptive Resistance to KRAS and MEK Inhibitors by Co-targeting mTORC1/2 Complexes in Pancreatic Cancer. DOI 10.1016/j.xcrm.2020.100131↗
- Paper Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response t… DOI 10.1053/j.gastro.2019.05.004↗
- Shoukat Dedhar · 3 shared papers, 2019–2024 · strength 0.36
- Paper Pancreatic cancer tumor organoids exhibit subtype-specific differences in metabolic profiles. DOI 10.1186/s40170-024-00357-z↗
- Paper Overcoming Adaptive Resistance to KRAS and MEK Inhibitors by Co-targeting mTORC1/2 Complexes in Pancreatic Cancer. DOI 10.1016/j.xcrm.2020.100131↗
- Paper Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response t… DOI 10.1053/j.gastro.2019.05.004↗
- Joanna M. Karasinska · 2 shared papers, 2019–2024 · strength 0.25
- Steve E. Kalloger · 2 shared papers, 2019–2024 · strength 0.25
- James Thomas Topham · 2 shared papers, 2019–2024 · strength 0.25
- Jinyang Li · 2 shared papers, 2019–2020 · strength 0.18
- Paper Overcoming Adaptive Resistance to KRAS and MEK Inhibitors by Co-targeting mTORC1/2 Complexes in Pancreatic Cancer. DOI 10.1016/j.xcrm.2020.100131↗
- Paper Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response t… DOI 10.1053/j.gastro.2019.05.004↗
- Wells S. Brown · 2 shared papers, 2019–2020 · strength 0.18
- Paper Overcoming Adaptive Resistance to KRAS and MEK Inhibitors by Co-targeting mTORC1/2 Complexes in Pancreatic Cancer. DOI 10.1016/j.xcrm.2020.100131↗
- Paper Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response t… DOI 10.1053/j.gastro.2019.05.004↗
- Ben Z. Stanger · 2 shared papers, 2019–2020 · strength 0.18
- Paper Overcoming Adaptive Resistance to KRAS and MEK Inhibitors by Co-targeting mTORC1/2 Complexes in Pancreatic Cancer. DOI 10.1016/j.xcrm.2020.100131↗
- Paper Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response t… DOI 10.1053/j.gastro.2019.05.004↗
- Seth J. Parker · 1 shared paper, 2024 · strength 0.18
- Hassan A. Ali · 1 shared paper, 2024 · strength 0.18
- Lan Valerie Tao · 1 shared paper, 2024 · strength 0.18
- Ali Bashashati · 1 shared paper, 2019 · strength 0.07
- Donald T. T. Yapp · 1 shared paper, 2019 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.